On December 14, 2022, Medifron DBT Co., Ltd. closed the transaction. The company issued 3,427,600 shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,445 KRW | +2.77% | +5.47% | -13.63% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,473 KRW | -0.47% | +2.08% | 90.62M | ||
1,445 KRW | +2.77% | +5.47% | 75.53M | ||
1st Jan change | Capi. | |
---|---|---|
-13.63% | 75.53M | |
-13.47% | 191B | |
+1.02% | 166B | |
+6.07% | 159B | |
+8.23% | 103B | |
+36.82% | 84.49B | |
+11.59% | 82.27B | |
-5.71% | 71.3B | |
-18.24% | 54.34B | |
-8.39% | 43.63B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd